Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer

CONCLUSIONS: DEB-TACE has a promising effect in the treatment of primary or secondary liver cancer. The treatment-related adverse reactions are tolerable.PMID:37153689 | PMC:PMC10156455 | DOI:10.1155/2023/5492931
Source: Canadian Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research